Category: Defective Prescription Drugs

BCH Represented at HarrisMartin MDL Conference Attorney Aaron Heckaman recently spoke at HarrisMartin’s MDL Conference: Managing Mass Torts on Key Litigation Updates and Lessons Learned. The seminar took place last week, where speakers covered mass ...

A new study published in the scientific journal Retina suggests long-term exposure to Elmiron – pentosan polysulfate sodium (PPS) – may increase a person’s risk of vision loss and other vision problems. Elmiron, a drug that treats pai ...

Zantac and its manufacturer Sanofi are under harsh scrutiny and potentially facing a wave of lawsuits, perhaps through multidistrict litigation (MDL), after it was announced that the popular heartburn medication could cause cancer&nbsp ...

Active pharmaceutical ingredient (API) manufacturer Zhejiang Huahai Pharmaceuticals was placed on import alert on Friday, September 28 by the U.S. Food and Drug Administration (FDA). The company will determine how its products, used in valsartan-cont ...

The U.S. Food and Drug Administration (FDA) recently announced a voluntary recall of drugs that contain valsartan, an active ingredient in a number of products meant to treat heart failure and high blood pressure. While not all products con ...

People suffering from Helicobacter pylori, a type of stomach bacteria that increases the risk of stomach cancer and ulcers, may still be at risk of stomach cancer even after antibiotic treatment eliminates the bacterium. A new study published by rese ...

According to a new trial, Invokana has shown an increased risk of leg, foot, and toe amputations. The United States Food and Drug Administration is now releasing an alert to the public regarding the ongoing research involving the use of Invokana (can ...

As we have noted before, the long-term use of proton pump inhibitors has been linked to an increased risk of serious conditions including heart disease, dementia, and more. Before now, however, researchers were not sure of why this was the case. Now, ...

Attorneys who are representing patients in lawsuits against two big drug markets are claiming that the makers of these drugs withheld important information from a leading medical journal. The companies, Johnson & Johnson and Bayer, are being call ...

In May of 2015, the Food and Drug Administration issued warnings regarding the Type 2 diabetes medication Invokana and its link to diabetic ketoacidosis. This condition can be very serious leading to high levels of ketones in the body. Ther ...